Gestational glucose abnormalities
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Enrolled and registered at our hospital in early pregnancy (gestational age <13 weeks), and plans to complete subsequent prenatal check-ups and delivery at our hospital; 2.Aged 18 years or above; 3.Singleton pregnancy; 4.Voluntarily participates in this study, signs the informed consent form, and commits to being able and willing to complete the following requirements according to the study protocol: (1) Undergoes standardized oral glucose tolerance test screening during pregnancy; (2) Wears and uses continuous glucose monitoring devices and wearable devices (such as Xiaomi Band 10) as required; (3) Completes research questionnaires regularly; (4) Provides biological samples as required; 5.Has a fixed residence locally, no plans to relocate during the study period, ensuring the ability to complete study follow-up; 6.No severe underlying diseases (such as heart, liver, kidney dysfunction, etc.); 7.No diseases that may affect blood glucose or exercise capacity, such as no motor dysfunction, no history of severe exercise-impairing injuries in the past 6 months; 8.No history of ocular diseases before pregnancy (such as retinopathy, ocular trauma, etc.).
Exclusion criteria
Exclusion criteria: 1.Serious Pregnancy Complications: Have or develop serious pregnancy complications at enrollment or during the study, such as preeclampsia, placental abruption, uncontrolled thyroid disease, etc.; 2.Contraindications to CGM or Wearable Devices (e.g., severe allergy or discomfort); 3.Inability to Proficiently Use Smartphones or Related Monitoring Devices After Training; 4.Other Exclusionary Conditions: The investigator determines the existence of any other condition that makes the participant unsuitable for this study (e.g., psychiatric illness preventing cooperation, history of substance abuse, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gestational blood glucose;Vision;Intraocular pressure;Fundus imaging;Macular thickness;Corneal nerve density;Diopter;Axial length;Corneal curvature;Retinal vascular morphology; | — |
Countries
China
Contacts
Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University)